Literature DB >> 9268151

Mutational analyses support a model for the HRV2 2A proteinase.

W Sommergruber1, J Seipelt, F Fessl, T Skern, H D Liebig, G Casari.   

Abstract

The proteinase 2A of human rhinovirus 2 is a cysteine proteinase which contains a tightly bound Zn ion thought to be required for structural integrity. A three-dimensional model for human rhinovirus type 2 proteinase 2A (HRV2 2A) was established using sequence alignments with small trypsin-like Ser-proteinases and, for certain regions, elastase. The model was tested by expressing selected proteinase 2A mutants in bacteria and examining the effect on both intramolecular ("cis") and intermolecular ("trans") activities. The HRV2 proteinase 2A is proposed to have a two domain structure, with the catalytic site and substrate binding region on one face of the molecule and a Zn-binding motif on the opposite face. Residues Gly 123, Gly 124, Thr 121, and Cys 101 are proposed to be involved in the architecture of the substrate binding pocket and to provide the correct environment for the catalytic triad of His 18, Asp 35, and Cys 106. Residues Tyr 85 and Tyr 86 are thought to participate in substrate recognition. The presence of an extensive C-terminal helix, in which Asp 132, Arg 134, Phe 130, and Phe 136 play important roles, explains why mutations in this region are generally detrimental to proteinase activity. The proposed Zn-binding motif comprises Cys 52, Cys 54, Cys 112, and His 114. Exchange of these residues inactivates the enzyme. Furthermore, as measured by atom emission spectroscopy, Zn was absent from purified preparations of proteinase 2A in which His 114 had been replaced by Asn. The absence of disulphide bridges was confirmed by subjecting highly purified HRV2 proteinase 2A to one- and two-step alkylation procedures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268151     DOI: 10.1006/viro.1997.8595

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Identification of mouse hepatitis virus papain-like proteinase 2 activity.

Authors:  A Kanjanahaluethai; S C Baker
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Characterization of the zinc binding activity of the rubella virus nonstructural protease.

Authors:  X Liu; J Yang; A M Ghazi; T K Frey
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  The multifaceted poliovirus 2A protease: regulation of gene expression by picornavirus proteases.

Authors:  Alfredo Castelló; Enrique Alvarez; Luis Carrasco
Journal:  J Biomed Biotechnol       Date:  2011-04-14

4.  Structure-Function Mutational Analysis and Prediction of the Potential Impact of High Risk Non-Synonymous Single-Nucleotide Polymorphism on Poliovirus 2A Protease Stability Using Comprehensive Informatics Approaches.

Authors:  Amna Younus; Saba Munawar; Muhammad Faraz Bhatti; Aqsa Ikram; Faryal Mehwish Awan; Ishrat Jabeen; Nasar Virk; Hussnain Ahmed Janjua; Muhammad Arshad
Journal:  Genes (Basel)       Date:  2018-04-26       Impact factor: 4.096

5.  A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold .

Authors:  J Herold; S G Siddell; A E Gorbalenya
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

6.  Molecular modeling and analysis of hepatitis E virus (HEV) papain-like cysteine protease.

Authors:  Mohammad Khalid Parvez; Azmat Ali Khan
Journal:  Virus Res       Date:  2013-12-07       Impact factor: 3.303

7.  NBCZone: Universal three-dimensional construction of eleven amino acids near the catalytic nucleophile and base in the superfamily of (chymo)trypsin-like serine fold proteases.

Authors:  Alexander I Denesyuk; Mark S Johnson; Outi M H Salo-Ahen; Vladimir N Uversky; Konstantin Denessiouk
Journal:  Int J Biol Macromol       Date:  2020-03-06       Impact factor: 8.025

Review 8.  Rhinovirus Inhibitors: Including a New Target, the Viral RNA.

Authors:  Antonio Real-Hohn; Dieter Blaas
Journal:  Viruses       Date:  2021-09-07       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.